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Table
Genetic risk scores for glycemic traits in relation to prevalent OA
Knee OA
OR (95% CI)*
Hip OA
OR (95% CI)*
Hand OA
OR (95% CI)*
Fasting
Glucose
0.91 (0.85–0.97)** 0.98 (0.90–1.07) 0.97 (0.92–1.03)
Fasting
Insulin
0.98 (0.92–1.05) 0.95 (0.87–1.04) 1.00 (0.95–1.07)
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morphisms acting on GNL3 and SPCS1 contribute to the OA association
signal at chromosome 3p21. The SNP used to study AEI for GNL3 was
rs11177whilst the one used for SPCS1 was rs6617. These two SNPs are in
high LD with each other (r2 ¼ 0.93), such that the minor alleles for both
SNPs are inherited together in a haplotype that correlates tightly with
the association signal. As both genes show reduced expression of the
OA-associated allele, it seems possible that they are co-ordinately
regulated. Functionally, although the association signal correlates with
only a small decrease in expression of each gene, an individual carrying
the associated allele will carry the shared haplotype and shall therefore
be subjected to the combined effect of a lower expression of both genes.
We hypothesise that this combined effect contributes to the increased
risk of developing OA that maps to this region of the genome. SPCS1
codes for signal peptidase complex subunit 1 homolog, a subunit of a
complex that acts to cleave signal sequences from secretory and
membrane proteins in the lumen of the endoplasmic reticulum. GNL3
codes for guanine nucleotide binding protein-like 3, also known as
nucleostemin. This protein is concentrated in stem cell nucleoli, and is
known tomodulate p53 function, thereby performing a role in cell cycle
regulation and cell proliferation and self-renewal. GNL3 also has a
broader role in maintenance of nucleolar structure and telomerase
activity. Our results now justify much more detailed investigation of
these two genes, and of their encoded proteins, in the context of OA
etiology.
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IS TYPE 2 DIABETES RELATED TO OSTEOARTHRITIS? A MENDELIAN
RANDOMISATION STUDY THAT INVESTIGATES GLYCEMIC TRAITS
AND OSTEOARTHRITIS
T.A. Hoeven, P.S. de Vries, A. Dehghan, O.H. Franco, A. Hofman,
P.J. Bindels, S.M. Bierma-Zeinstra, J.B. van Meurs. Erasmus Univ. Med.
Ctr., Rotterdam, Netherlands
Purpose: Previous studies examining the relationship between type 2
diabetes mellitus (DM) and osteoarthritis (OA) have presented con-
ﬂicting results that are further hampered bymethodological issues such
as reverse causality, measurement error or possible confounding by
lifestyle factors and baseline health status. Hence, it remains unclear
whether DM and OA are associated and/or causally related. One way to
address causation in epidemiology, particularly in chronic diseases, is
the use of mendelian randomization. The random assortment of alleles
at the time of gamete formation results in population distributions of
genetic variants that are generally independent of behavioral factors
that confound epidemiological associations. In other words, mendelian
randomization through genetic risk factors might overcome con-
founding and reverse causality, which hamper the interpretation of
classical epidemiological studies. We therefore investigated whether
genetically deﬁned elevated levels of glycemic traits (fasting glucose
and fasting insulin) were associated with the presence of OA of the
knee, hip and hand in a large population-based study.
Methods: In a population-based cohort study involving participants
aged 45 years and older (the Rotterdam Study), genotypes and cova-
riates were collected at baseline (n ¼ 10,213; mean age 66.0 years; 41%
men). We constructed weighted genetic risk scores based on single-
nucleotide polymorphisms (SNPs) known to be associated with fasting
insulin (n ¼ 11 SNPs) or fasting glucose (n ¼ 36 SNPs), independent of
body mass index. SNPs that were known to be associated with both
fasting insulin and fasting glucose levels were excluded. X-rays were
scored using the Kellgren–Lawrence score for OA at baseline and
osteoarthritis was deﬁned as a Kellgren–Lawrence score 2. We ana-
lysed the genetic risk scores for their association with presence of OA
using logistic regression analysis.
Results:Within the study population, 17% had radiographic knee OA, 8%
hip OA, and 29% hand OA. The genetic risk scores for fasting glucose and
fasting insulin levels were associated with fasting glucose levels and
fasting insulin levels in the population (p¼ 4.39 1030, and p¼ 1.77
105 respectively) and explained 0.9% and 0.4% of the total variance of
the glycemic traits. No signiﬁcant association was found between the
fasting insulin genetic risk and OA-prevalence. However, genetically
deﬁned higher glucose levels were associated with a lower risk for knee
OA. Unadjusted analyses showed similar results.*Adjusted for age, sex, body mass index, hypertension, cholesterol ratio,
and smoking. **p < 0.01
Conclusions: In this population-based cohort study persons with
increased genetic risk scores for glycemic traits were not at higher risk
of OA. These ﬁrst analyses using genetically deﬁned elevated levels of
fasting insulin and fasting glucose point in the direction of a non-causal
role for diabetes mellitus type 2 in the development of osteoarthritis.
The use of genetic risk scores might be a way to disentangle complex
associations prone to confounding.
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A GENOME WIDE ASSOCIATION STUDY OF PRESSURE PAIN
THRESHOLD IN THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT
Y. Liu y, A. Goode z, W. Maixner x, S. Smith x, J.M. Jordan y. y Thurston
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Purpose: Pressure pain threshold (PPT) is a biological marker of indi-
vidual pain perception that has been found to be signiﬁcantly associated
with symptomatic knee and hip osteoarthritis (OA). Although p in is a
well-known heritable phenotype, previous studies to identify genes
associated with PPT have not been conducted. The purpose of these
analyses was to identify single nucleotide polymorphisms (SNPs) asso-
ciated with PPT among African Americans, Caucasians and Caucasian
Men and Women.
Methods: These analyses consist of 1,199 participants with complete
genome enrolled in the Johnston County Osteoarthritis (JoCo) Project
between 2003 and 2004. PPT measurements were averaged over three
trials from left and right trapezius muscles using a standard baseline
dolorimeter. Since over 63% of participants had PPT measures >4 kg we
created a dichotomous variable to represent participants with low PPT
(<4kg), as the referent, and high PPT (4 kg), as the index. Genome
wide genotyping was conducted among all participants using the Illu-
mina Inﬁnium 1M-Duo array. Single marker analysis was performed
using logistic regression adjusting for sex, race, age, body mass index
(BMI) and Center for Epidemiologic Studies Depression (CES-D) Scale
score. Genome wide association (GWAS) analysis was conducted in
Caucasians and African Americans separately. Sex speciﬁc GWAS anal-
ysis was performed in Caucasians to investigate the genetic difference
between men and women. GWAS statistical signiﬁcance was set at
10e-8.
Results: Participants, mean age was 68.1 (SD 9.0), 63.0% female,
36.4% African American, mean body mass index (BMI) 31.2 Kg/m2
(SD ¼ 7.0 Kg/m2) and a mean Center for Epidemiologic Studies
Depression (CES-D) Scale score of 6.5 (SD 7.4). Sex, age, BMI and
CES-D scale were all statistically signiﬁcantly associated with PPT (p
< 0.01). GWAS analysis results indicated no SNP reached a 10e-8
signiﬁcance level. Six SNPs had p-values less than 10e-7. Among
these six SNPs, ﬁve are located in the coding regions of three genes
(PLD5, ZNF253 and ZNF93). PLD5 (Phospholipase D Family, Member
5) had been reported to be associated with multiple sclerosis.
ZNF253 and ZNF93 both belong to Zinc Finger Protein family and
may be involved in transcriptional regulation. All the six SNPs are
also signiﬁcant in sex speciﬁc analysis. In addition, rs11916152
(located in MGLL gene) was associated with PPT in men only (p ¼
9.83e-6) and rs6967902 (located in DYNC1I1 gene) in women only
(p ¼ 4.71e-6). MGLL gene plays a critical role in several physiological
processes including pain while the DYNC1I1 gene is related with the
Table
SNPs associated with PPT in African Americans, Caucasians and Caucasian men and women
Subjects Sample size CHR SNP Gene Base pair Reference allele Odds ratio P value
Caucasians 883 1 rs2636249 PLD5 240474093 T 0.42 7.90E-7
19 rs8113576 ZNF253 19849681 T 0.48 4.34E-7
19 rs10412710 ZNF253 19854507 C 0.48 3.32E-7
19 rs28590063 ZNF93 19873070 C 0.49 3.49E-7
19 rs13344370 ZNF93 19882046 T 0.49 4.13E-7
Caucasian women 543 7 rs6967902 DYNC1I1 95347742 G 0.51 4.71E-6
Caucasian men 340 3 rs11916152 MGLL 128932251 T 0.15 9.83E-6
African Americans 316 4 rs1264978 STK32B 5171498 A 0.13 5.51E-6
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cated in African American subjects.
Conclusions: PPT was associated with several SNPs located in three
genes with plausible relationships to pain, with some SNPs differing
by sex. That these SNPs were not replicated in African Americans
might be due to genetic differences between populations or sample
size limitations. These results will be evaluated in other painful
conditions.
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EXPRESSION PROFILE OF LONG NONCODING RNAS IN
OSTEOARTHRITIS PATIENTS
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Purpose: Long noncoding RNAs (lncRNAs) have emerged as a novel
class of regulatory molecules involved in various biological processes
and complex diseases. In this study, we aimed to explore the potential
role of lncRNAs in osteoarthritis.
Methods: Six OA knee cartilage and ﬁve normal cartilage samples
were used. The expression proﬁles of lncRNAs and mRNAs
between osteoarthritic and normal cartilage tissue were obtained
using microarray essay and differently expressed lncRNAs were
primarily veriﬁed using qRT-PCR. The co-expressed mRNAs of the
lncRNAs were identiﬁed by calculating Pearson Correlation with
correlation P-value <0.05 and a functional enrichment analysis of
this set of co-expressed mRNAs were conducted to predicted
functional term (Gene Ontology and KEGG pathway) of given
lncRNA. The potential cis- or trans-regulated target genes and co-
regulated transcription factors of lncRNAs were also predicted by
bioinformatics analysis.
Results: 4067 lncRNAs wereup-regulated and 2231 lncRNAs were
down-regulated (2.0-fold changes, p < 0.05) in the OA group
when compared to the normal group (Fig. 1). Hundreds of differ-
entially expressed mRNAs were found to co-express with each of
the given lncRNAs. GO analysis revealed that the highest enriched
GO targeted by differentially expressed lncRNAs were cell cycle
process (ontology: biological process), intracellular part (ontology:
cellular component) and RNA binding (ontology: molecular func-
tion). Pathway analysis indicated that 16 pathways were related to
the differentially expressed transcripts and that the most enriched
one was “Oxidative phosphorylation”. Up to 23 mRNAs with sig-
niﬁcant Pearson correlation of lncRNA-mRNA expression were
identiﬁed as cis-regulated targets of a given lncRNA. Furthermore,
594 differentially expressed lncRNAs may exert their function
through the transcription factor “CTCF”, and 438 target genes of
CTCF were predicted as the trans-regulated targets of these
lncRNAs (Fig. 2).
Conclusions: It is the ﬁrst study to present the lncRNAs expression
proﬁle in OA. These results indicated that lots of lncRNAs were aber-
rantly expressed in osteoarthritic cartilage compared with normal
samples, which suggested that lncRNAs may play a role in pathogenesis
of OA and may be potential biomarkers or therapic targets of OA.Fig. 1. Heat Map and Hierarchical Clustering. The result of hierarchical
clustering, which was performed based on “Differentially Expressed
LncRNAs”, showed distinguishable LncRNAs expression proﬁling among
samples.
Fig. 2. The core network of IncRNAs-transcription factor-target genes. Red
core presents IncRNA, green core presents transcription factor, orange
core presents target gene. Lots of genes targeted by CTCF were predicted
as targets genes of these two IncRNAs.
